260 related articles for article (PubMed ID: 20565834)
1. Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis.
Zhao Q; Barclay M; Hilkens J; Guo X; Barrow H; Rhodes JM; Yu LG
Mol Cancer; 2010 Jun; 9():154. PubMed ID: 20565834
[TBL] [Abstract][Full Text] [Related]
2. Peanut agglutinin appearance in the blood circulation after peanut ingestion mimics the action of endogenous galectin-3 to promote metastasis by interaction with cancer-associated MUC1.
Zhao Q; Duckworth CA; Wang W; Guo X; Barrow H; Pritchard DM; Rhodes JM; Yu LG
Carcinogenesis; 2014 Dec; 35(12):2815-21. PubMed ID: 25326505
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion.
Yu LG; Andrews N; Zhao Q; McKean D; Williams JF; Connor LJ; Gerasimenko OV; Hilkens J; Hirabayashi J; Kasai K; Rhodes JM
J Biol Chem; 2007 Jan; 282(1):773-81. PubMed ID: 17090543
[TBL] [Abstract][Full Text] [Related]
4. Serum galectin-2, -4, and -8 are greatly increased in colon and breast cancer patients and promote cancer cell adhesion to blood vascular endothelium.
Barrow H; Guo X; Wandall HH; Pedersen JW; Fu B; Zhao Q; Chen C; Rhodes JM; Yu LG
Clin Cancer Res; 2011 Nov; 17(22):7035-46. PubMed ID: 21933892
[TBL] [Abstract][Full Text] [Related]
5. Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface.
Zhao Q; Guo X; Nash GB; Stone PC; Hilkens J; Rhodes JM; Yu LG
Cancer Res; 2009 Sep; 69(17):6799-806. PubMed ID: 19690136
[TBL] [Abstract][Full Text] [Related]
6. Sialylation regulates galectin-3/ligand interplay during mammary tumour progression--a case of targeted uncloaking.
de Oliveira JT; de Matos AJ; Santos AL; Pinto R; Gomes J; Hespanhol V; Chammas R; Manninen A; Bernardes ES; Albuquerque Reis C; Rutteman G; Gärtner F
Int J Dev Biol; 2011; 55(7-9):823-34. PubMed ID: 22161838
[TBL] [Abstract][Full Text] [Related]
7. Thermodynamic Switch in Binding of Adhesion/Growth Regulatory Human Galectin-3 to Tumor-Associated TF Antigen (CD176) and MUC1 Glycopeptides.
Rodriguez MC; Yegorova S; Pitteloud JP; Chavaroche AE; André S; Ardá A; Minond D; Jiménez-Barbero J; Gabius HJ; Cudic M
Biochemistry; 2015 Jul; 54(29):4462-74. PubMed ID: 26129647
[TBL] [Abstract][Full Text] [Related]
8. Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients.
Saeland E; Belo AI; Mongera S; van Die I; Meijer GA; van Kooyk Y
Int J Cancer; 2012 Jul; 131(1):117-28. PubMed ID: 21823122
[TBL] [Abstract][Full Text] [Related]
9. Interaction of galectin-3 with MUC1 on cell surface promotes EGFR dimerization and activation in human epithelial cancer cells.
Piyush T; Chacko AR; Sindrewicz P; Hilkens J; Rhodes JM; Yu LG
Cell Death Differ; 2017 Nov; 24(11):1937-1947. PubMed ID: 28731466
[TBL] [Abstract][Full Text] [Related]
10. Endogenous and exogenous galectin-3 promote the adhesion of tumor cells with low expression of MUC1 to HUVECs through upregulation of N-cadherin and CD44.
Cao Z; Hao Z; Xin M; Yu L; Wang L; Zhang Y; Zhang X; Guo X
Lab Invest; 2018 Dec; 98(12):1642-1656. PubMed ID: 30171204
[TBL] [Abstract][Full Text] [Related]
11. Binding of Galectin-3, a β-Galactoside-binding Lectin, to MUC1 Protein Enhances Phosphorylation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) and Akt, Promoting Tumor Cell Malignancy.
Mori Y; Akita K; Yashiro M; Sawada T; Hirakawa K; Murata T; Nakada H
J Biol Chem; 2015 Oct; 290(43):26125-40. PubMed ID: 26342075
[TBL] [Abstract][Full Text] [Related]
12. Lactose-functionalized dendrimers arbitrate the interaction of galectin-3/MUC1 mediated cancer cellular aggregation.
Michel AK; Nangia-Makker P; Raz A; Cloninger MJ
Chembiochem; 2014 Sep; 15(14):2106-12. PubMed ID: 25138772
[TBL] [Abstract][Full Text] [Related]
13. Binding of galectin-1 to breast cancer cells MCF7 induces apoptosis and inhibition of proliferation in vitro in a 2D- and 3D- cell culture model.
Geiger P; Mayer B; Wiest I; Schulze S; Jeschke U; Weissenbacher T
BMC Cancer; 2016 Nov; 16(1):870. PubMed ID: 27825375
[TBL] [Abstract][Full Text] [Related]
14. Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells.
Glinsky VV; Huflejt ME; Glinsky GV; Deutscher SL; Quinn TP
Cancer Res; 2000 May; 60(10):2584-8. PubMed ID: 10825125
[TBL] [Abstract][Full Text] [Related]
15. The human endometrium expresses the glycoprotein mucin-1 and shows positive correlation for Thomsen-Friedenreich epitope expression and galectin-1 binding.
Jeschke U; Walzel H; Mylonas I; Papadopoulos P; Shabani N; Kuhn C; Schulze S; Friese K; Karsten U; Anz D; Kupka MS
J Histochem Cytochem; 2009 Sep; 57(9):871-81. PubMed ID: 19506091
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells.
Kim HR; Lin HM; Biliran H; Raz A
Cancer Res; 1999 Aug; 59(16):4148-54. PubMed ID: 10463621
[TBL] [Abstract][Full Text] [Related]
17. MUC1 extracellular domain confers resistance of epithelial cancer cells to anoikis.
Zhao Q; Piyush T; Chen C; Hollingsworth MA; Hilkens J; Rhodes JM; Yu LG
Cell Death Dis; 2014 Oct; 5(10):e1438. PubMed ID: 25275599
[TBL] [Abstract][Full Text] [Related]
18. Galectin-3 and Epithelial MUC1 Mucin-Interactions Supporting Cancer Development.
Radziejewska I
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345016
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of prostate cancer bone metastasis by synthetic TF antigen mimic/galectin-3 inhibitor lactulose-L-leucine.
Glinskii OV; Sud S; Mossine VV; Mawhinney TP; Anthony DC; Glinsky GV; Pienta KJ; Glinsky VV
Neoplasia; 2012 Jan; 14(1):65-73. PubMed ID: 22355275
[TBL] [Abstract][Full Text] [Related]
20. Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer.
Gentilini LD; Jaworski FM; Tiraboschi C; Pérez IG; Kotler ML; Chauchereau A; Laderach DJ; Compagno D
Oncotarget; 2017 Jul; 8(27):44654-44668. PubMed ID: 28591719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
